937046-96-3

Basic information

• Product Name: tert-butyl 2-cyano-1H-pyrrol-1-ylcarbaMate
• Synonyms: tert-butyl 2-cyano-1H-pyrrol-1-ylcarbaMate;1-N-BOC-AMINO-2-CYANOPYRROLE;CarbaMic acid, N-(2-cyano-1H-pyrrol-1-yl)-, 1,1-diMethylethyl ester;1-(Boc-aMino)-2-cyanopyrr...;1-(Boc-aMino)-2-cyanopyrrole;N-(2-cyano-1H-pyrrol-1-yl)(tert-butoxy)formamide;tert-Butyl (2-cyano-1H-pyrrol-1-yl)
• CAS NO: 937046-96-3
• Molecular Formula: C10H13N3O2
• Molecular Weight: 207
• Mol File: 937046-96-3.mol
• Article Data: 12

Chemical Properties

• Appearance: /
• Density: 1.12
• Storage Temp.: Inert atmosphere,Room Temperature
• PKA: 4.28±0.46(Predicted)
• CAS DataBase Reference: tert-butyl 2-cyano-1H-pyrrol-1-ylcarbaMate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 2-cyano-1H-pyrrol-1-ylcarbaMate(937046-96-3)
• EPA Substance Registry System: tert-butyl 2-cyano-1H-pyrrol-1-ylcarbaMate(937046-96-3)

Safety Data

• Hazardous Substances Data: 937046-96-3(Hazardous Substances Data)

Usage

Uses

1-N-Boc-Amino-2-cyanopyrrole is a useful research chemical.

Upstream product

• 1189-71-5 isocyanate de chlorosulfonyle 
• 937046-95-2 N-(1H-pyrrol-1-yl)-carbamic acid tert-butyl ester 
• 870-46-2 t-butoxycarbonylhydrazine 
• 5176-27-2 N-tert-butyloxycarbonyl-pyrrole 

Downstream Products

• 888720-29-4 4-chloropyrrolo[1,2-f][1,2,4]triazine 
• 1201784-90-8 6-bromopyrrolo[2,1-f][1,2,4]triazine-2,4(1H,3H)-dione 
• 937046-98-5 7-bromo-pyrrolo[2,1-f][1,2,4]triazin-4-ylamine 
• 1426665-82-8 4-(3,4-dihydro-4,9,11,11a-tetraazadibenzo[cd,f]azulen-3-yl)-2-fluorophenol 
• 1426665-76-0 4-(3,4-dihydro-4,9,11,11a-tetraazadibenzo[cd,f]azulen-3-yl)-2-methylphenol 
• 1426665-71-5 4-(3,4-dihydro-4,9,11,11a-tetraazadibenzo[cd,f]azulen-3-yl)-3-methylphenol 
• 1426665-66-8 2,6-dichloro-4-(3,4-dihydro-4,9,11,11a-tetraazadibenzo[cd,f]azulen-3-yl)phenol 
• 1426665-58-8 2-(4,9,11,11a-tetraazadibenzo[cd,f]azulen-3-yl)-5-methoxyphenol 
• 1426665-53-3 2-chloro-4-(3,4-dihydro-4,9,11,11a-tetraazadibenzo[cd,f]azulen-3-yl)-6-methoxyphenol 
• 1426665-46-4 2-chloro-4-(3,4-dihydro-4,9,11,11a-tetraazadibenzo[cd,f]azulen-3-yl)phenol 
• 1426665-40-8 2-bromo-4-(3,4-dihydro-4,9,11,11a-tetraazadibenzo[cd,f]azulen-3-yl)phenol 
• 1426665-35-1 2-chloro-3-(3,4-dihydro-4,9,11,11a-tetraazadibenzo[cd,f]azulen-3-yl)-6-methoxyphenol 
• 1426665-30-6 4-(3,4-dihydro-4,9,11,11a-tetraazadibenzo[cd,f]azulen-3-yl)benzene-1,2-diol 
• 1426665-25-9 2-(3,4-dihydro-4,9,11,11a-tetraazadibenzo[cd,f]azulen-3-yl)-5-methoxyphenol 

Relevant articles and documents

FGFR INHIBITOR AND MEDICAL APPLICATION THEREOF

Provided is a FGFR inhibitor, designating a compound represented by formula (I) or a pharmaceutically acceptable salt thereof. Also provided is the application of a drug for treating solid tumors, such as FGFR related diseases.

THE MONOHYDRATE OF ROGARATINIB HYDROCHLORIDE AND SOLID STATES THEREOF

Compound (III) which is the crystalline form of [4-{[4-amino-6-(methoxymethyl)-5-(7-methoxy-5-methyl-l-benzothiophen-2-yl)pyrrolo[2, -f] [ 1,2,4]triazin-7-yl]methyl}piperazin-2-one hydrochloride] which is the monohydrate, processes for its preparation, pharmaceutical compositions comprising it and its use in the control of disorders, including cancer.

Discovery of Rogaratinib (BAY 1163877): a pan-FGFR Inhibitor

Rogaratinib (BAY 1163877) is a highly potent and selective small-molecule pan-fibroblast growth factor receptor (FGFR) inhibitor (FGFR1–4) for oral application currently being investigated in phase 1 clinical trials for the treatment of cancer. In this publication, we report its discovery by de novo structure-based design and medicinal chemistry optimization together with its pharmacokinetic profile.